Annual Accounts Payable
$762.00 K
-$391.00 K-33.91%
December 31, 2022
Summary
- As of February 10, 2025, RXDX annual accounts payable is $762.00 thousand, with the most recent change of -$391.00 thousand (-33.91%) on December 31, 2022.
- During the last 3 years, RXDX annual accounts payable has fallen by -$642.00 thousand (-45.73%).
Performance
RXDX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Payable
$1.16 M
+$399.00 K+52.36%
March 31, 2023
Summary
- As of February 10, 2025, RXDX quarterly accounts payable is $1.16 million, with the most recent change of +$399.00 thousand (+52.36%) on March 31, 2023.
- Over the past year, RXDX quarterly accounts payable has dropped by -$651.00 thousand (-35.93%).
Performance
RXDX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
RXDX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -33.9% | -35.9% |
| 3 y3 years | -45.7% | - |
| 5 y5 years | -45.7% | - |
RXDX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -33.9% | at low | -35.9% | -60.2% |
| 5 y | 5-year | -45.7% | at low | -48.4% | -60.2% |
| alltime | all time | -45.7% | at low | -48.4% | -60.2% |
Prometheus Biosciences Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $1.16 M(+52.4%) |
| Dec 2022 | $762.00 K(-33.9%) | $762.00 K(-29.3%) |
| Sep 2022 | - | $1.08 M(+133.3%) |
| Jun 2022 | - | $462.00 K(-74.5%) |
| Mar 2022 | - | $1.81 M(+57.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $1.15 M(+20.4%) | $1.15 M(-30.7%) |
| Sep 2021 | - | $1.66 M(-26.1%) |
| Jun 2021 | - | $2.25 M(+8.1%) |
| Mar 2021 | - | $2.08 M(+117.3%) |
| Dec 2020 | $958.00 K(-31.8%) | $958.00 K |
| Dec 2019 | $1.40 M | - |
FAQ
- What is Prometheus Biosciences annual accounts payable?
- What is the all time high annual accounts payable for Prometheus Biosciences?
- What is Prometheus Biosciences annual accounts payable year-on-year change?
- What is Prometheus Biosciences quarterly accounts payable?
- What is the all time high quarterly accounts payable for Prometheus Biosciences?
- What is Prometheus Biosciences quarterly accounts payable year-on-year change?
What is Prometheus Biosciences annual accounts payable?
The current annual accounts payable of RXDX is $762.00 K
What is the all time high annual accounts payable for Prometheus Biosciences?
Prometheus Biosciences all-time high annual accounts payable is $1.40 M
What is Prometheus Biosciences annual accounts payable year-on-year change?
Over the past year, RXDX annual accounts payable has changed by -$391.00 K (-33.91%)
What is Prometheus Biosciences quarterly accounts payable?
The current quarterly accounts payable of RXDX is $1.16 M
What is the all time high quarterly accounts payable for Prometheus Biosciences?
Prometheus Biosciences all-time high quarterly accounts payable is $2.25 M
What is Prometheus Biosciences quarterly accounts payable year-on-year change?
Over the past year, RXDX quarterly accounts payable has changed by -$651.00 K (-35.93%)